IRCCS Azienda Ospedaliero-Universitaria di Bologna
569
257
294
150
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
1.9%
11 terminated/withdrawn out of 569 trials
93.2%
+6.6% vs industry average
5%
26 trials in Phase 3/4
1%
2 of 150 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (569)
Cefepime/Enmetazobactam for Bacteremic Complicated Urinary Tract Infections
Role: lead
Role of the Gut Microbiome in the Outcome of Diffuse Large B-Cell Lymphoma Patients Treated With CAR-T Cell Therapy
Role: collaborator
INfections in Patients Treated With CAR-T
Role: lead
Radiomics Analysis of CMR Imaging for Arrhythmic Risk Prediction in Hypertrophic Cardiomyopathy, With Longitudinal Risk Reassessment After Mavacamten Therapy in Obstructive Patients
Role: collaborator
Emotional Allodynia Questionnaire (AEQ) in Fibromyalgia (PEARL)
Role: collaborator
Comparison Between Two Hysteroscopic Biopsy Techniques in the Outpatient Setting for Sampling Hypotrophic or Atrophic Endometrium: 'Rail Biopsy' Versus 'Chip Biopsy'
Role: lead
The Effect of Ultrasound Visual Feedback on Birth Outcomes in Nulliparous Women With Levator Ani Muscle Co-activation at Term Pregnancy
Role: lead
Assessment of Ovarian Reserve in the Treatment of Ovarian Endometrioma With Cystectomy or Argon Plasma Coagulation: A Aandomized Clinical Trial
Role: lead
Assessment of Cardiac and Carotid Ultrasound Measurements in a Cohort of Healthy Children in Italy
Role: lead
ASSESSMENT OF THE NATURAL HISTORY AND PROGNOSTIC FACTORS OF THERAPEUTIC RESPONSE IN SUB-PHENOTYPES OF PATIENTS WITH OBESITY: THE BOLOBE STUDY
Role: lead
Respiratory Exacerbations in Children With Bronchopulmonary Dysplasia (BPD): A Case-Control Study
Role: lead
The Use of Artificial Intelligence for Ultrasound Screening of Ovarian Cancer in Postmenopausal Women
Role: lead
Impact of Culture of Perfusion Fluid on Donor-derived Infection Management and Outcome in Liver and Kidney Transplant
Role: lead
Comparison Diagnostic Tests for the Diagnosis of CYTOmegalovirus Organ Disease in Patients With intestinalBOweL Diseases
Role: lead
Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients
Role: lead
Epidemiology, Risk Factors, and Outcomes of Infections of Lower Limb MEGAprostheses
Role: lead
PK/PD Relationship of CAZ/AVI and FOS in the Treatment of Patients With Infections Due to CRE
Role: lead
BIOmarker Based Diagnostic TOOLkit to Personalise Pharmacological Approaches in Congestive Heart Failure: the BIOTOOL-CHF Validation Trial
Role: lead
Fecal Microbiota Transplantation to RESCUE Patients With Unresectable Hcc Progressors to First Line Therapy With AtezolizUmaB and Bevacizumab
Role: lead
Identification of the Best Treatment Pathway for Patients With Relapsed/Refractory Lymphocytic B-derived Non-Hodgkin Lymphoma
Role: lead